PortViewPortView
ObsEva S.A. logo

ObsEva S.A. (OBSV) Stock Analysis

NASDAQHealthcareBiotechnology

$0.10+0.00%
1-year price historyRange $0.08 – $2.08
52-week range$0.10
$0.07$2.14

What ObsEva S.A. does

ObsEva S.A. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for conditions affecting women's reproductive health and pregnancy. A key part of their development pipeline is Linzagolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, currently in Phase III clinical trials. This drug aims to mitigate pain associated with endometriosis and reduce heavy menstrual bleeding stemming from uterine fibroids in pre-menopausal women. Additionally, the company is progressing Ebopiprant, a selective oral prostaglandin F2a (PGF2a) receptor antagonist, through Phase II trials as a once-daily therapy for preterm labor occurring between 24 and 34 weeks of gestation. Their portfolio also includes Nolasiban, an oral oxytocin receptor antagonist in Phase I clinical development, designed to enhance clinical pregnancy and live birth outcomes for women undergoing in vitro fertilization. Founded in 2012, ObsEva S.A. operates from its headquarters in Geneva, Switzerland.

Key metrics

Market cap
$11.00M
P/E (TTM)
-0.14
EPS (TTM)
$-0.74
Beta
0.67
Dividend yield
0.00%
Revenue / share
$0.21
50-day avg
$0.14
200-day avg
$0.27
52-week high
$2.14
52-week low
$0.07
CEO
William Michael Brown

ETFs linked to OBSV

Broad-market and Healthcare sector ETFs an investor holding ObsEva S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OBSV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OBSV in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for ObsEva S.A.?
ObsEva S.A. trades under the ticker OBSV on NASDAQ.
Which exchange is OBSV listed on?
OBSV is listed on NASDAQ.
What sector does ObsEva S.A. operate in?
ObsEva S.A. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OBSV in a portfolio?
PortView shows OBSV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.